Clinical trial
A Randomized, Controlled, Double-Masked Adaptive Design Evaluation of the Safety and Preliminary Efficacy of IVMED-85 on Pediatric Myopia
NCT05761795 is registered in ClinicalTrials.gov with iVeena Delivery Systems, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Controlled, Double-Masked Adaptive Design Evaluation of the Safety and Preliminary Efficacy of IVMED-85 on Pediatric Myopia
- Lead sponsor
- iVeena Delivery Systems, Inc.
- Phase
- Phase 1/2
- Overall status
- Not yet recruiting
- Start date
- February 29, 2024
- Completion date
- December 31, 2026
- Enrollment
- 216 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
myopia, progressive